Cargando…
Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing
Prostate cancer (PC) is one of the most common types of cancer in males. Although early stages of PC are generally associated with favorable outcomes, advanced phases of the disease present a significantly poorer prognosis. Moreover, currently available therapeutic options for the treatment of PC ar...
Autores principales: | Bernal, Leonardo, Pinzi, Luca, Rastelli, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964599/ https://www.ncbi.nlm.nih.gov/pubmed/36834548 http://dx.doi.org/10.3390/ijms24043135 |
Ejemplares similares
-
Trends and Applications in Computationally Driven Drug Repurposing
por: Pinzi, Luca, et al.
Publicado: (2023) -
Chemoinformatics Analyses of Tau Ligands Reveal Key Molecular Requirements for the Identification of Potential Drug Candidates against Tauopathies
por: Pinzi, Luca, et al.
Publicado: (2021) -
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
por: Pinzi, Luca, et al.
Publicado: (2021) -
On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017) -
Molecular Docking: Shifting Paradigms in Drug Discovery
por: Pinzi, Luca, et al.
Publicado: (2019)